These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2328213

  • 1. How frequent is spontaneous remission of neuroblastomas? Implications for screening.
    Carlsen NL.
    Br J Cancer; 1990 Mar; 61(3):441-6. PubMed ID: 2328213
    [Abstract] [Full Text] [Related]

  • 2. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
    Carlsen NL.
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
    [Abstract] [Full Text] [Related]

  • 3. Neuroblastomas in Denmark 1943-80. Epidemiological and clinical studies.
    Carlsen NL.
    Acta Paediatr Suppl; 1994 Oct; 403():1-27. PubMed ID: 7841631
    [Abstract] [Full Text] [Related]

  • 4. [Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies].
    Carlsen NL.
    Ugeskr Laeger; 1992 Dec 21; 154(52):3742-6. PubMed ID: 1471302
    [No Abstract] [Full Text] [Related]

  • 5. Epidemiological investigations on neuroblastomas in Denmark 1943-1980.
    Carlsen NL.
    Br J Cancer; 1986 Dec 21; 54(6):977-88. PubMed ID: 3099820
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma. Evaluation of 60 cases.
    Carlsen NL, Nielsen OH, Hertz H.
    Acta Paediatr Scand; 1981 Jan 21; 70(1):61-6. PubMed ID: 7211378
    [Abstract] [Full Text] [Related]

  • 7. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe.
    Powell JE, Estève J, Mann JR, Parker L, Frappaz D, Michaelis J, Kerbl R, Mutz ID, Stiller CA.
    Lancet; 1998 Aug 29; 352(9129):682-7. PubMed ID: 9728983
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E, Iehara T, Sugimoto T, Fukuzawa M, Hayashi Y, Sasaki F, Sugiyama M, Kondo S, Yoneda A, Yamaoka H, Tajiri T, Akazawa K, Ohtaki M.
    Lancet; 2008 Apr 05; 371(9619):1173-80. PubMed ID: 18395578
    [Abstract] [Full Text] [Related]

  • 9. Why age has independent prognostic significance in neuroblastomas. Evidence for intra-uterine development, and implications for the treatment of the disease.
    Carlsen NL.
    Anticancer Res; 1988 Apr 05; 8(2):255-62. PubMed ID: 3364937
    [Abstract] [Full Text] [Related]

  • 10. Italian cancer figures, report 2012: Cancer in children and adolescents.
    AIRTUM Working Group, CCM, AIEOP Working Group.
    Epidemiol Prev; 2013 Apr 05; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous regression of neuroblastoma.
    Evans AE, Gerson J, Schnaufer L.
    Natl Cancer Inst Monogr; 1976 Nov 05; 44():49-54. PubMed ID: 1030781
    [Abstract] [Full Text] [Related]

  • 12. [Epidemiology of neuroblastoma in Brittany over a 10-year period (1980-1989)].
    Blanchot I, Bergeron C, Roussey M, De Parscau L, Le Gall E.
    Pediatrie; 1993 Nov 05; 48(3):217-22. PubMed ID: 8393978
    [Abstract] [Full Text] [Related]

  • 13. [Neuroblastoma in the Rhone-Alpes area: epidemiologic data].
    Renaux P, Mathieu P, Chauvin F, Collet JP, Greffe J, Lacroix C, Narod S, Vocanson M, Ducos-Mieral C, Boschetti R.
    Pediatrie; 1990 Nov 05; 45(1):59-64. PubMed ID: 2158051
    [Abstract] [Full Text] [Related]

  • 14. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
    Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F.
    J Clin Oncol; 2008 Mar 20; 26(9):1504-10. PubMed ID: 18349403
    [Abstract] [Full Text] [Related]

  • 15. Neuroblastoma screening data. An epidemiologic analysis.
    Goodman SN.
    Am J Dis Child; 1991 Dec 20; 145(12):1415-22. PubMed ID: 1669671
    [Abstract] [Full Text] [Related]

  • 16. Maturation of mass-screened localized adrenal neuroblastoma.
    Iwanaka T, Yamamoto K, Ogawa Y, Arai M, Ito M, Kishimoto H, Hanada R, Imaizumi S.
    J Pediatr Surg; 2001 Nov 20; 36(11):1633-6. PubMed ID: 11685689
    [Abstract] [Full Text] [Related]

  • 17. High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma.
    Sartelet H, Ohta S, Barrette S, Rougemont AL, Brevet M, Regairaz M, Harvey I, Bernard C, Fabre M, Gaboury L, Oligny LL, Bosq J, Valteau-Couanet D, Vassal G.
    Histopathology; 2010 Apr 20; 56(5):607-16. PubMed ID: 20459571
    [Abstract] [Full Text] [Related]

  • 18. Observations on the histopathology of neuroblastomas.
    Beckwith JB, Martin RF.
    J Pediatr Surg; 1968 Feb 20; 3(1):106-10. PubMed ID: 5655555
    [No Abstract] [Full Text] [Related]

  • 19. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 20; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 20. Neuroblastoma sympathicum.
    Koutecký J.
    Acta Univ Carol Med Monogr; 1984 Jul 20; 106():1-133. PubMed ID: 6391118
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.